Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Ravat, Panvichian"'
Autor:
Woraseth Saifon, Insee Sensorn, Narumol Trachu, Songporn Oranratnachai, Angkana Charoenyingwattana, Chakkaphan Runcharoen, Nanamon Monnamo, Warawut Sukkasem, Pimpin Inchareon, Thitiporn Suwatanapongched, Phichai Chansriwong, Touch Ativitavas, Ravat Panvichian, Wasun Chantratita, Thanyanan Reungwetwattana
Publikováno v:
BMC Cancer, Vol 22, Iss 1, Pp 1-15 (2022)
Abstract Introduction Difference in clinical responses to cancer therapy in each patient is from several factors. Gastrointestinal microbiota is one of the reasons. However, this correlation remains unknown. This study aims to explore correlation bet
Externí odkaz:
https://doaj.org/article/176aa5f49a35468c8c834abeb4721e19
Autor:
Anchalee Tantiwetrueangdet, Ravat Panvichian, Pattana Sornmayura, Surasak Leelaudomlipi, Jill A. Macoska
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-12 (2021)
Abstract Background PCNA-associated factor, the protein encoded by the KIAA0101/PCLAF gene, is a cell-cycle regulated oncoprotein that regulates DNA synthesis, maintenance of DNA methylation, and DNA-damage bypass, through the interaction with the hu
Externí odkaz:
https://doaj.org/article/d60cf3e348c54fd6929597d9c8f6af07
Publikováno v:
Cell & Bioscience, Vol 10, Iss 1, Pp 1-15 (2020)
Abstract Background Epidermal growth factor receptor (EGFR) has emerged as an important therapeutic target. Overexpression of EGFR is frequently observed in hepatocellular carcinoma (HCC) and EGFR activation has been proven to be a potential determin
Externí odkaz:
https://doaj.org/article/b7582e006a2248a490c57b1068634258
Autor:
Anchalee Tantiwetrueangdet, Ravat Panvichian, Sansanee Wongwaisayawan, Pitichai Phornsarayuth, Panuwat Lertsithichai
HER2 amplification/overexpression is the predictive biomarker for HER2-targeted therapy. However, there are technical limitations to HER2 detection by fluorescence in situ hybridization (FISH) and immunohistochemistry (IHC). Recently, novel HER2-dire
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3b71305cada2d7a8d63f172f687ec2a4
https://doi.org/10.21203/rs.3.rs-2892947/v1
https://doi.org/10.21203/rs.3.rs-2892947/v1
Autor:
Watchalawalee Yamkaew, Songporn Oranratnachai, Nareenart Iemwimangsa, Ravat Panvichian, Atchara Tunteeratum, Thongchai Sukarayothin
Germline mutations in BRCA1/2 are the most common cause of hereditary breast and ovarian cancer (HBOC) syndrome. A few studies have reported the prevalence of germline BRCA mutations in Asian patients with breast cancer. Here, we aimed to explore the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6799988f83fe30cd803bc42e3fa649ad
https://doi.org/10.21203/rs.3.rs-591403/v1
https://doi.org/10.21203/rs.3.rs-591403/v1
Autor:
Ravat Panvichian, Anchalee Tantiwetrueangdet, Surasak Leelaudomlipi, Pattana Sornmayura, Jill A. Macoska
Publikováno v:
BMC Cancer
BMC Cancer, Vol 21, Iss 1, Pp 1-12 (2021)
BMC Cancer, Vol 21, Iss 1, Pp 1-12 (2021)
Background PCNA-associated factor, the protein encoded by the KIAA0101/PCLAF gene, is a cell-cycle regulated oncoprotein that regulates DNA synthesis, maintenance of DNA methylation, and DNA-damage bypass, through the interaction with the human slidi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5a270666a1a27bfb729f28f92c155fb5
https://doi.org/10.1186/s12885-021-07994-3
https://doi.org/10.1186/s12885-021-07994-3
Background PCNA-associated factor (KIAA0101/p15PAF) is a cell-cycle regulated oncoprotein that regulates DNA synthesis, maintenance of DNA methylation, and DNA-damage bypass, through the interaction with the human sliding clamp PCNA. KIAA0101 is over
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5bf9b8cb7ff4d9c44be25cb8f11a9b33
https://doi.org/10.21203/rs.3.rs-39782/v1
https://doi.org/10.21203/rs.3.rs-39782/v1
Autor:
W. Sukasem, P. Inchareon, Thanyanan Reungwetwattana, Ravat Panvichian, Touch Ativitavas, Wasun Chantratita, Angkana Charoenyingwattana, N. Trachu, N. Monnamo, Chakkaphan Runcharoen, W. Saifon, Songporn Oranratnachai, Pichai Chansriwong
Publikováno v:
Annals of Oncology. 32:S977
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5ea3b7df1eb494a1b23ac4fde605bb10
https://doi.org/10.1016/j.annonc.2021.08.1842
https://doi.org/10.1016/j.annonc.2021.08.1842
Publikováno v:
Cell & Bioscience
Cell & Bioscience, Vol 10, Iss 1, Pp 1-15 (2020)
Cell & Bioscience, Vol 10, Iss 1, Pp 1-15 (2020)
Background Epidermal growth factor receptor (EGFR) has emerged as an important therapeutic target. Overexpression of EGFR is frequently observed in hepatocellular carcinoma (HCC) and EGFR activation has been proven to be a potential determinant of pr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::713a83c53aedb02d8c5b688d8bd19196
https://pubmed.ncbi.nlm.nih.gov/32190291
https://pubmed.ncbi.nlm.nih.gov/32190291
Autor:
Sansanee Wongwaisayawan, Panuwat Lertsithichai, Ravat Panvichian, Anchalee Tantiwetrueangdet, Natthaporn Sueangoen
Publikováno v:
Medical Oncology (Northwood, London, England)
Breast cancers with amplification and overexpression of human epithelial growth factor receptor 2 (HER2) are associated with poor prognosis, and targeted for anti-HER2 therapy. Immunohistochemistry (IHC) and fluorescence in situ hybridization (FISH)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::60ee01ff45802dfec33772eb1e3e94ec
https://pubmed.ncbi.nlm.nih.gov/30284063
https://pubmed.ncbi.nlm.nih.gov/30284063